Webb30 mars 2024 · Proficiency with all standard NGS analysis tools and cancer genomics software (e.g. BWA, MuTect). • Clinical study design for translational research and biomarker development. Oncology expertise focused on advanced prostate cancer management, clinical trials and RWD, and genomic testing. • Data science and statistics. Webb6 aug. 2014 · The European Randomised study of Screening for Prostate Cancer (ERSPC) has shown significant reductions in prostate cancer mortality after 9 years and 11 years of follow-up, but screening is controversial because of adverse events such as overdiagnosis.
RESEARCH PLAN: ProScreen (Prostate Cancer Screening Trial) 1 ...
Webb13 apr. 2024 · Randomization to PSA screening was not associated with reduced risk of prostate cancer mortality in either a US trial with substantial control group … Webb8 mars 2024 · New risk algorithm would improve screening for prostate cancer 8 March 2024 Calculating a person’s risk of developing prostate cancer using results from two blood markers would improve the accuracy of screening for the disease, reports a new study led by a UCL researcher. famous people born on 9/27
Mortality results from the Göteborg randomised population-based ...
WebbGiven that prior screening trials included men aged up to 70 yr on starting screening, our results suggest that the effect size reported in prior trials underestimates that of currently recommended programs starting at age 50–55 yr. ... 24-year follow-up of the Göteborg randomized population-based prostate cancer screening trial. WebbJuliana Pereira - 26 years old - Nurse - Graduate student in Oncology - Clinical Research. Experience in clinical research for more than 4 years. Some of the activities carried out: - Screening of patients for inclusion/exclusion in studies - Patient recruitment - Presentation and application of TCLE - Collection of data … WebbPurpose We examined whether the survival advantage of androgen-deprivation therapy with radiotherapy (ADT plus RT) relative to ADT alone for men with locally advanced prostate cancer reported in two randomized trials holds in real-world clinical practice and extended the evidence to patients poorly represented in the trials. Methods We … cop wah